Clinical Trial Update: Oral Metformin for Treatment of ABCA4 Retinopathy [Phase 1, Phase 2]

View source ↗

Summary

An oral metformin trial for ABCA4 retinopathy and Stargardt disease is in Phase 1/Phase 2 and currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Abca4 Retinopathy
• Retinal Degeneration
• Retinal Dystrophy
• Stargardt Disease

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: National Eye Institute (NEI) | Conditions: ABCA4 Retinopathy, Stargardt Disease | Phase 1, Phase 2 | Status: RECRUITING